Amgen Inc.

    AMGN ·NASDAQ ·Biological Products, (No Diagnostic Substances) ·Inc. in DE
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-05-02 10-Q expected by 2026-05-08 (in 1 day)
    • ~2026-08-06 10-Q expected by 2026-08-12 (in 97 days)
    • ~2026-11-05 10-Q expected by 2026-11-11 (in 188 days)
    • ~2027-02-12 10-K expected by 2027-03-01 (in 287 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-30 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-04-22 8-K Officer/Director Change; Financial Statements and Exhibits
    • 2026-04-07 DEF 14A Proxy Statement
    • 2026-02-19 8-K Material Agreement Entered; Financial Statements and Exhibits
    • 2026-02-13 10-K Annual Report
    • 2026-02-03 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-01-30 8-K Material Agreement Terminated; Financial Statements and Exhibits
    • 2025-11-05 10-Q Quarterly Report
    • 2025-11-04 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-08-06 10-Q Quarterly Report
    • 2025-08-05 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-05-02 10-Q Quarterly Report
    • 2025-05-01 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-02-14 10-K Annual Report
    • 2025-02-04 8-K Earnings Release; Financial Statements and Exhibits